rediff.com
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570
Oxygenta Pharmaceutical Ltd - Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29 Of SEBI (LODR) Regulations, 2015 And In Terms Of Aforesaid SEBI Circular Dated May 20, 2020 And All Other Applicable Regulations And Closure Of Trading Window
Download announcement < Back
03 Nov 2022
Oxygenta Pharmaceutical Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve This is to inform you that a meeting of Board of Directors of the Company is scheduled to be held on Saturday, 12th November, 2022, inter-alia, to consider and approve: 1. The Un-audited Financial Results for the quarter and half year ended 30th September, 2022: 2. Other Corporate matters As per the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 read with the Code of conduct to Regulate, Monitor and Report Trading by insiders of the Company, the Trading window for dealing in the equity shares of the Company was closed from 01st October, 2022, till 48 hours after the declaration of financial results for the quarter and half year ended 30th September, 2022, for all designated persons, their immediate relatives and all connected persons covered under the said Code. This is for your information and records.
View all announcements for Oxygenta Pharmaceutical Ltd Source: BSE India

Mutual Fund Selector

Find the fund that is right for you

Buy? Sell? Hold?

Get the Latest Stock Tips